New theme ETF from VanEck on Xetra: access to companies from the field of bionics technology

A new exchange-traded fund issued by VanEck has been tradable on Xetra and via the trading venue Börse Frankfurt since Wednesday.

The VanEck Bionic Engineering UCITS ETF offers exposure to companies in the bionics technology space. Bionics is a technical field concerned with the research and development of mechanical systems that closely mimic the functions or parts of living organisms.

Companies are considered that derive their income from medical, dental, and vision-related implants, bioprinting, prostheses or the preservation of organs and tissue. Producers of implantable and wearable devices or materials that are only used for cosmetic purposes are excluded.

The fund pursues a sustainable investment strategy.

NameAsset classISINOn-going chargesDistribution policyReference index
VanEck Bionic Engineering UCITS ETFEquity ETFIE0005TF96I90.55 per centaccumulatingMVIS Global Bionic Healthcare ESG Index

The product offering in Deutsche Börse’s XTF segment currently comprises a total of 1,994 ETFs. With this selection and an average monthly trading volume of around €19 billion, Xetra is the leading trading venue for ETFs in Europe.

Published on December 7, 2022

Share this Article